RE:RE:RE:RE:RE:I am hoping the company maximizes this AUA event This is strange. The original presentation relating to the Phase 1 b clinical trial by Lothar Lilge, Angelica Manalac, Leonid Vesselov, Wayne Embree, Arkady Mandel, Naughan Betz, Michael Jewett and Girish Kulkani was replaced by a different presentation on Bladder Cancer: Non Invasive II with session moderators: Mark S. Soloway, Boris Gershman and Paul David Anderson.
If you go to the original presentation details though, it clearly states: Source of Funding: Theralase Technologies and the Government of Ontario.
Either presenters had to back out of this prestigious presentation or maybe there is an issue with the disclosure that the Govmt of Ontario has been (or possibly continues to be) involved in funding.
All sounds a bit mysterious.